|
1
|
Keum N and Giovannucci E: Global burden of
colorectal cancer: Emerging trends, risk factors and prevention
strategies. Nat Rev Gastroenterol Hepatol. 16:713–732. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Galon J and Bruni D: Tumor Immunology and
tumor evolution: Intertwined histories. Immunity. 52:55–81. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
IJsselsteijn ME, Sanz-Pamplona R, Hermitte
F and de Miranda NFCC: Colorectal cancer: A paradigmatic model for
cancer immunology and immunotherapy. Mol Aspects Med. 69:123–129.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmitt M and Greten FR: The inflammatory
pathogenesis of colorectal cancer. Nat Rev Immunol. 21:653–667.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lv Y, Zhao Y, Wang X, Chen N, Mao F, Teng
Y, Wang T, Peng L, Zhang J, Cheng P, et al: Increased intratumoral
mast cells foster immune suppression and gastric cancer progression
through TNF-α-PD-L1 pathway. J Immunother Cancer. 7:542019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hallgren J and Gurish MF: Mast cell
progenitor trafficking and maturation. Adv Exp Med Biol. 716:14–28.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dahlin JS, Malinovschi A, Öhrvik H,
Sandelin M, Janson C, Alving K and Hallgren J: Lin-CD34hi
CD117int/hi FcεRI+ cells in human blood constitute a rare
population of mast cell progenitors. Blood. 127:383–391. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marone G, Galli SJ and Kitamura Y: Probing
the roles of mast cells and basophils in natural and acquired
immunity, physiology and disease. Trends Immunol. 23:425–427. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maltby S, Khazaie K and McNagny KM: Mast
cells in tumor growth: Angiogenesis, tissue remodelling and
immune-modulation. Biochim Biophys Acta. 1796:19–26.
2009.PubMed/NCBI
|
|
10
|
Komi DEA and Redegeld FA: Role of mast
cells in shaping the tumor microenvironment. Clin Rev Allergy
Immunol. 58:313–325. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagata M, Shijubo N, Walls AF, Ichimiya S,
Abe S and Sato N: Chymase-positive mast cells in small sized
adenocarcinoma of the lung. Virchows Arch. 443:565–573. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mangia A, Malfettone A, Rossi R, Paradiso
A, Ranieri G, Simone G and Resta L: Tissue remodelling in breast
cancer: Human mast cell tryptase as an initiator of myofibroblast
differentiation. Histopathology. 58:1096–1106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ranieri G, Ammendola M, Patruno R, Celano
G, Zito FA, Montemurro S, Rella A, Di Lecce V, Gadaleta CD,
Battista De Sarro G and Ribatti D: Tryptase-positive mast cells
correlate with angiogenesis in early breast cancer patients. Int J
Oncol. 35:115–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo X, Zhai L, Xue R, Shi J, Zeng Q and
Gao C: Mast cell tryptase contributes to pancreatic cancer growth
through promoting angiogenesis via activation of angiopoietin-1.
Int J Mol Sci. 17:8642016. View Article : Google Scholar
|
|
15
|
Ammendola M, Sacco R, Sammarco G, Donato
G, Montemurro S, Ruggieri E, Patruno R, Marech I, Cariello M, Vacca
A, et al: Correlation between serum tryptase, mast cells positive
to tryptase and microvascular density in colo-rectal cancer
patients: Possible biological-clinical significance. PLoS One.
9:e995122014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gulubova M and Vlaykova T: Prognostic
significance of mast cell number and microvascular density for the
survival of patients with primary colorectal cancer. J
Gastroenterol Hepatol. 24:1265–1275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Malfettone A, Silvestris N, Saponaro C,
Ranieri G, Russo A, Caruso S, Popescu O, Simone G, Paradiso A and
Mangia A: High density of tryptase-positive mast cells in human
colorectal cancer: A poor prognostic factor related to
protease-activated receptor 2 expression. J Cell Mol Med.
17:1025–1037. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suzuki S, Ichikawa Y, Nakagawa K, Kumamoto
T, Mori R, Matsuyama R, Takeda K, Ota M, Tanaka K, Tamura T and
Endo I: High infiltration of mast cells positive to tryptase
predicts worse outcome following resection of colorectal liver
metastases. BMC Cancer. 15:8402015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Acikalin MF, Oner U, Topçu I, Yaşar B,
Kiper H and Colak E: Tumour angiogenesis and mast cell density in
the prognostic assessment of colorectal carcinomas. Dig Liver Dis.
37:162–169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Amin MB, Gress DM, Meyer Vega LR, Edge SB,
Greene FL, Byrd DR, Brookland RK, Washington MK and Compton CC:
AJCC Cancer Staging Manual. 8th edition. Springer; New York, NY:
2017, View Article : Google Scholar
|
|
21
|
Xia Q, Wu XJ, Zhou Q, Jing-Zeng .Hou JH,
Pan ZZ and Zhang XS: No relationship between the distribution of
mast cells and the survival of stage IIIB colon cancer patients. J
Transl Med. 9:882011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu Y, Blokhuis B, Derks Y, Kumari S,
Garssen J and Redegeld F: Human mast cells promote colon cancer
growth via bidirectional crosstalk: Studies in 2D and 3D coculture
models. Oncoimmunology. 7:e15047292018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gounaris E, Erdman SE, Restaino C, Gurish
MF, Friend DS, Gounari F, Lee DM, Zhang G, Glickman JN, Shin K, et
al: Mast cells are an essential hematopoietic component for polyp
development. Proc Natl Acad Sci USA. 104:19977–19982. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dahlin JS and Hallgren J: Mast cell
progenitors: Origin, development and migration to tissues. Mol
Immunol. 63:9–17. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Drew E, Huettner CS, Tenen DG and McNagny
KM: CD34 expression by mast cells: Of mice and men. Blood.
106:1885–1887. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Z, Zhu Y, Xu L, Zhang J, Xie H, Fu H,
Zhou Q, Chang Y, Dai B and Xu J: Tumor stroma-infiltrating mast
cells predict prognosis and adjuvant chemotherapeutic benefits in
patients with muscle invasive bladder cancer. Oncoimmunology.
7:e14743172018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bo X, Wang J, Suo T, Ni X, Liu H, Shen S,
Li M, Wang Y, Liu H and Xu J: Tumor-infiltrating mast cells predict
prognosis and gemcitabine-based adjuvant chemotherapeutic benefit
in biliary tract cancer patients. BMC Cancer. 18:3132018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Varricchi G, Galdiero MR, Loffredo S,
Marone G, Iannone R, Marone G and Granata F: Are mast cells MASTers
in cancer? Front Immunol. 8:4242017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu G, Wang S and Cheng P:
Tumor-infiltrating tryptase(+) mast cells predict unfavorable
clinical outcome in solid tumors. Int J Cancer. 142:813–821. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mehdawi L, Osman J, Topi G and Sjölander
A: High tumor mast cell density is associated with longer survival
of colon cancer patients. Acta Oncol. 55:1434–1442. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tan SY, Fan Y, Luo HS, Shen ZX, Guo Y and
Zhao LJ: Prognostic significance of cell infiltrations of
immunosurveillance in colorectal cancer. World J Gastroenterol.
11:1210–1214. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nielsen HJ, Hansen U, Christensen IJ,
Reimert CM, Brünner N and Moesgaard F: Independent prognostic value
of eosinophil and mast cell infiltration in colorectal cancer
tissue. J Pathol. 189:487–495. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Curran T, Sun Z, Gerry B, Findlay VJ,
Wallace K, Li Z, Paulos C, Ford M, Rubinstein MP, Chung D and Camp
ER: Differential immune signatures in the tumor microenvironment
are associated with colon cancer racial disparities. Cancer Med.
10:1805–1814. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu K, Miao L, Chen W, Wu H, Gong Y, Tu X,
Gou W, Pan B, Qu C, Wu X and Wang B: Establishment of the reference
intervals of lymphocyte subsets for healthy Chinese Han adults and
its influencing factors. Ann Transl Med. 9:14952021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wernersson S and Pejler G: Mast cell
secretory granules: Armed for battle. Nat Rev Immunol. 14:478–494.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huber M, Cato ACB, Ainooson GK, Freichel
M, Tsvilovskyy V, Jessberger R, Riedlinger E, Sommerhoff CP and
Bischoff SC: Regulation of the pleiotropic effects of
tissue-resident mast cells. J Allergy Clin Immunol. 144 (Suppl
4):S31–S45. 2019. View Article : Google Scholar : PubMed/NCBI
|
